Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,161 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00420927 | Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis(OPTIMA) | completed | Phase 4 | 1,032 | AbbottINDUSTRY | 21 | Apr 18, 2012 | clinicaltrials |
| NCT01336257 | Effectiveness of a Decision Support System in Improving the Diagnosis and Screening Rate of Breast Cancer | unknown | N/A | 2,200 | Hospital Italiano de Buenos AiresOTHER | 1 | Apr 17, 2012 |
| clinicaltrials |
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | completed | Phase 3 | 1,065 | Novartis PharmaceuticalsINDUSTRY | 28 | Apr 16, 2012 | clinicaltrials |
| NCT00171314 | The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer | completed | Phase 3 | 527 | Novartis PharmaceuticalsINDUSTRY | 9 | Apr 11, 2012 | clinicaltrials |
| NCT00094029 | A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248 | approved for marketing | — | — | PfizerINDUSTRY | 34 | Mar 9, 2012 | clinicaltrials |
| NCT00130897 | Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma | approved for marketing | — | — | PfizerINDUSTRY | 50 | Mar 9, 2012 | clinicaltrials |
| NCT00432562 | A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. | completed | Phase 1 | 31 | Mast Therapeutics, Inc.INDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00124748 | Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)(TOPS) | terminated | Phase 3 | 476 | Novartis PharmaceuticalsINDUSTRY | 6 | Feb 3, 2012 | clinicaltrials |
| NCT00381654 | Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor Malignancies | terminated | Phase 1 | 27 | AVEO Pharmaceuticals, Inc.INDUSTRY | 2 | Oct 4, 2011 | clinicaltrials |
| NCT00630110 | Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 172 | Nereus Pharmaceuticals, Inc.INDUSTRY | 6 | Aug 16, 2011 | clinicaltrials |
| NCT00057720 | TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer | completed | Phase 3 | 440 | TelikINDUSTRY | 13 | Jul 25, 2011 | clinicaltrials |
| NCT00094653 | MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma | completed | Phase 3 | 1,783 | Bristol-Myers SquibbINDUSTRY | 13 | Jul 11, 2011 | clinicaltrials |
| NCT00415194 | A Study for Patients With Head and Neck Cancer | completed | Phase 3 | 795 | Eli Lilly and CompanyINDUSTRY | 21 | Jun 28, 2011 | clinicaltrials |
| NCT00489359 | Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer | completed | Phase 1 / Phase 2 | 86 | Eli Lilly and CompanyINDUSTRY | 5 | Jun 16, 2011 | clinicaltrials |
| NCT00550004 | Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine(RP101) | terminated | Phase 2 | 153 | SciClone PharmaceuticalsINDUSTRY | 13 | Jun 8, 2011 | clinicaltrials |
| NCT00076388 | Iressa Versus Docetaxel (Taxotere) | completed | Phase 3 | 1,440 | AstraZenecaINDUSTRY | 25 | May 13, 2011 | clinicaltrials |
| NCT00371345 | Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer | completed | Phase 2 | 92 | Bristol-Myers SquibbINDUSTRY | 7 | Apr 26, 2011 | clinicaltrials |
| NCT00101647 | Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia | completed | Phase 2 | 197 | Bristol-Myers SquibbINDUSTRY | 23 | Apr 15, 2011 | clinicaltrials |
| NCT00101595 | Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | completed | Phase 2 | 96 | Bristol-Myers SquibbINDUSTRY | 20 | Apr 14, 2011 | clinicaltrials |
| NCT00417079 | XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer(TROPIC) | completed | Phase 3 | 755 | SanofiINDUSTRY | 26 | Mar 10, 2011 | clinicaltrials |
| NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer(TAX316) | completed | Phase 3 | 1,491 | SanofiINDUSTRY | 20 | Feb 16, 2011 | clinicaltrials |
| NCT00206219 | Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) | completed | Phase 3 | 477 | AstraZenecaINDUSTRY | 25 | Jan 27, 2011 | clinicaltrials |
| NCT00401323 | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 / Phase 3 | 568 | SanofiINDUSTRY | 20 | Jan 20, 2011 | clinicaltrials |
| NCT00878930 | Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer(FRAME) | completed | — | 500 | AstraZenecaINDUSTRY | 1 | Jan 5, 2011 | clinicaltrials |
| NCT00715637 | Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study | unknown | Phase 3 | 420 | Antisoma ResearchINDUSTRY | 23 | Oct 13, 2010 | clinicaltrials |
| NCT00895674 | Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar | completed | — | 2,840 | BayerINDUSTRY | 18 | Sep 30, 2010 | clinicaltrials |
| NCT00418236 | Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density | completed | — | 400 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 14 | Aug 19, 2010 | clinicaltrials |
| NCT00103844 | Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 32 | Aug 10, 2010 | clinicaltrials |
| NCT00169572 | Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy | completed | Phase 2 | 492 | GlaxoSmithKlineINDUSTRY | 19 | May 10, 2010 | clinicaltrials |
| NCT00191139 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 4 | Feb 17, 2010 | clinicaltrials |
| NCT00191152 | A Phase III Trial For Patients With Metastatic Breast Cancer | completed | Phase 3 | 475 | Eli Lilly and CompanyINDUSTRY | 8 | Dec 24, 2009 | clinicaltrials |
| NCT00035425 | Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection | completed | Phase 3 | 120 | PfizerINDUSTRY | 10 | Dec 1, 2009 | clinicaltrials |
| NCT00363415 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 908 | Eli Lilly and CompanyINDUSTRY | 26 | Oct 28, 2009 | clinicaltrials |
| NCT00320515 | Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer | completed | Phase 1 / Phase 2 | 89 | Eli Lilly and CompanyINDUSTRY | 4 | Sep 28, 2009 | clinicaltrials |
| NCT00191100 | Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix | completed | Phase 3 | 515 | Eli Lilly and CompanyINDUSTRY | 7 | Aug 11, 2009 | clinicaltrials |
| NCT00664170 | A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer | completed | Phase 1 | 39 | Mast Therapeutics, Inc.INDUSTRY | 3 | May 28, 2009 | clinicaltrials |
| NCT00087958 | Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment | completed | Phase 2 | 168 | SanofiINDUSTRY | 15 | May 1, 2009 | clinicaltrials |
| NCT00099294 | Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer | completed | Phase 3 | 300 | Threshold PharmaceuticalsINDUSTRY | 11 | Apr 30, 2009 | clinicaltrials |
| NCT00055146 | Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) | completed | Phase 2 | 41 | Eisai Inc.INDUSTRY | 5 | Apr 17, 2009 | clinicaltrials |
| NCT00465491 | Study of Picoplatin Efficacy After Relapse(SPEAR) | unknown | Phase 3 | 399 | Poniard PharmaceuticalsINDUSTRY | 15 | Apr 14, 2009 | clinicaltrials |
| NCT00294996 | Trial of Myocet in Metastatic Breast Cancer | unknown | Phase 3 | 363 | Sopherion TherapeuticsINDUSTRY | 11 | Mar 31, 2009 | clinicaltrials |
| NCT00290953 | Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide(SESAME) | completed | Phase 2 / Phase 3 | 432 | SanofiINDUSTRY | 14 | Dec 23, 2008 | clinicaltrials |
| NCT00784615 | Evaluation of Endocrine and Metabolic Parameters in the New Diagnostic Phenotypes of Polycystic Ovary Syndrome | unknown | — | 80 | Universidad Nacional de CórdobaOTHER | 1 | Nov 19, 2008 | clinicaltrials |
| NCT00072852 | Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine | completed | Phase 2 | 134 | PfizerINDUSTRY | 5 | Oct 16, 2008 | clinicaltrials |
| NCT00081796 | Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | completed | Phase 3 | 438 | SanofiINDUSTRY | 26 | Aug 21, 2008 | clinicaltrials |
| NCT00679679 | Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome | completed | Phase 4 | 30 | Hospital Privado de Cordoba, ArgentinaOTHER | 1 | May 19, 2008 | clinicaltrials |
| NCT00460876 | Phase I Trial of Periocular Topotecan in Retinoblastoma | completed | Phase 1 | 5 | Hospital JP GarrahanOTHER_GOV | 1 | May 2, 2008 | clinicaltrials |
| NCT00434369 | 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients | unknown | Phase 2 | 31 | Mast Therapeutics, Inc.INDUSTRY | 5 | Apr 22, 2008 | clinicaltrials |
| NCT00080340 | Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 3 | 520 | TelikINDUSTRY | 8 | Jan 15, 2008 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials